San Diego, CA -- (SBWIRE) -- 11/19/2014 -- An investigation on behalf of current long-term investors in shares of Sarepta Therapeutics Inc (NASDAQ:SRPT) shares was announced over potential breaches of fiduciary duties by certain officers and directors at Sarepta Therapeutics.